AMGN vs. CAH: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at AMGN and CAH, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
AMGN dominates in value with a market cap of 145.90 billion USD, eclipsing CAH’s 36.59 billion USD by roughly 3.99×.
With betas of 0.50 for AMGN and 0.67 for CAH, both show similar volatility profiles relative to the overall market.
Symbol | AMGN | CAH |
---|---|---|
Company Name | Amgen Inc. | Cardinal Health, Inc. |
Country | US | US |
Sector | Healthcare | Healthcare |
Industry | Drug Manufacturers - General | Medical - Distribution |
CEO | Mr. Robert A. Bradway | Mr. Jason M. Hollar |
Price | 271.34 USD | 153.31 USD |
Market Cap | 145.90 billion USD | 36.59 billion USD |
Beta | 0.50 | 0.67 |
Exchange | NASDAQ | NYSE |
IPO Date | June 17, 1983 | August 4, 1983 |
ADR | No | No |
Performance Comparison
This chart compares the performance of AMGN and CAH over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
The section examines key financial ratios to assess the valuation of AMGN and CAH based on earnings, cash flow, sales, and book value. Pay attention to the following notable points where extreme values stand out.
- CAH carries a sub-zero price-to-book ratio of -12.48, indicating negative equity. In contrast, AMGN (P/B 23.52) has positive book value.
Symbol | AMGN | CAH |
---|---|---|
Price-to-Earnings Ratio (P/E, TTM) | 24.60 | 23.62 |
Forward PEG Ratio (TTM) | 7.08 | 1.95 |
Price-to-Sales Ratio (P/S, TTM) | 4.28 | 0.16 |
Price-to-Book Ratio (P/B, TTM) | 23.52 | -12.48 |
Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 13.37 | 15.00 |
EV-to-EBITDA (TTM) | 15.71 | 14.56 |
EV-to-Sales (TTM) | 5.70 | 0.18 |
EV-to-Free Cash Flow (TTM) | 17.82 | 16.79 |
Dividend Comparison
AMGN’s dividend yield of 3.41% is about 159% higher than CAH’s 1.32%, underscoring its stronger focus on returning cash to shareholders.
Symbol | AMGN | CAH |
---|---|---|
Dividend Yield (TTM) | 3.41% | 1.32% |
Financial Strength Metrics Comparison
This section dives into the financial resilience of AMGN and CAH, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.
- CAH’s current ratio of 0.94 indicates its assets may not cover near-term debts, whereas AMGN at 1.17 maintains healthy liquidity.
- CAH posts a quick ratio of 0.50, indicating limited coverage of short-term debts from its most liquid assets—while AMGN at 0.88 enjoys stronger liquidity resilience.
- AMGN carries high leverage (debt-to-equity ratio 9.24), whereas CAH has negative equity (-2.60), each presenting distinct capital-structure concerns.
Symbol | AMGN | CAH |
---|---|---|
Current Ratio (TTM) | 1.17 | 0.94 |
Quick Ratio (TTM) | 0.88 | 0.50 |
Debt-to-Equity Ratio (TTM) | 9.24 | -2.60 |
Debt-to-Assets Ratio (TTM) | 0.64 | 0.15 |
Interest Coverage Ratio (TTM) | 3.19 | 15.45 |